Google Übersetzer
Camurus Ab
About
525.50SEK-5.00 -0.94%
Closed • Updated at 23:10 GMT+00:00Market Cap$3.36B
P/E Ratio46.29
Volume86.8K
Beta1.36
RSI49.23
Gross Margin91.95%
Camurus Ab — investor relations, events, news, and company updates on 6ix.
Latest News
Jan 9 2026
Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly
Nov 10 2025
Camurus reports positive topline results for CAM2056, semaglutide monthly depot
Aug 28 2025
Camurus announces approval of Oczyesa® for the treatment of acromegaly in the UK
Jul 1 2025
Camurus' Oczyesa® receives marketing authorization for treatment of acromegaly in the EU
Jun 18 2025
Camurus' POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients
Community Chat
Ask AI
Try asking